Ultrasound Enhances ZD2767P–Carboxypeptidase G2 against Chemoresistant Ovarian Cancer Cells by Altering the Intracellular Pharmacokinetics of ZD2767D

药代动力学 卵巢癌 体内 药理学 前药 医学 癌症 内科学 生物 生物技术
作者
Qianfen Liu,Xiaocui Zhong,Ying Zhang,Xinya Li,Guanhua Qian,Tinghe Yu
出处
期刊:Molecular Pharmaceutics [American Chemical Society]
卷期号:17 (6): 1922-1932 被引量:11
标识
DOI:10.1021/acs.molpharmaceut.0c00008
摘要

Prodrug–carboxypeptidase G2 (e.g., ZD2767P+CPG2) can realize a targeted treatment where the specific advantage is a lack of CPG2 analogues in humans, but it is limited by low efficacy. Here ultrasound was employed to enhance ZD2767P+CPG2 (i.e., ZD2767P+CPG2+US) against chemoresistant human ovarian cancer cells. The release dynamics of ZD2767D (activated drug) by CPG2 were investigated. The in vitro efficacy was explored in SKOV3 and SKOV3/DDP (cisplatin-resistant subline) cells; spectrophotometry was established to quantify ZD2767P and ZD2767D, and then intracellular pharmacokinetics were evaluated. The in vivo efficacy was validated in both subcutaneous and orthotopic tumors. With insonation, the ZD2767D concentration was increased during an early period. Insonation synergized ZD2767P+CPG2 to enhance cell death and apoptosis, and efficacies in SKOV3 and SKOV3/DDP cells were similar. Intracellular pharmacokinetics of ZD2767D were nonproportional, and insonation increased the peak level, area under the level vs time curve, and mean residence time. In subcutaneous xenografts, ZD2767P+CPG2 and ZD2767P+CPG2+US resulted in volume-inhibitory rates of 20.4% and 26.5% in SKOV3 tumors and 36.8% and 81.6% in SKOV3/DDP tumors, respectively. In the orthotopic tumor model, the survival time in group ZD2767P+CPG2 or ZD2767P+CPG2+US was prolonged compared with group control, in SKOV3 (33.0 ± 3.5 or 39.2 ± 1.8 vs 25.0 ± 1.6 days, p < 0.0001) and SKOV3/DDP (16.2 ± 4.8 or 22.3 ± 7.3 vs 8.7 ± 3.9 days, p = 0.0015) tumors. These data indicated that ZD2767P+CPG2+US was effective against resistant ovarian cancer cells.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
甜美阁完成签到,获得积分10
刚刚
孙杰完成签到,获得积分20
1秒前
哇samm完成签到,获得积分10
1秒前
冬冬完成签到,获得积分0
2秒前
单车完成签到 ,获得积分10
2秒前
3秒前
冬亿思念你完成签到,获得积分20
3秒前
李健的应助被Akirus采纳,获得30
3秒前
3秒前
MR_Z完成签到,获得积分10
3秒前
笨笨罡完成签到 ,获得积分10
3秒前
斌糖排骨完成签到,获得积分10
4秒前
4秒前
淡然一德完成签到,获得积分10
4秒前
4秒前
科研通AI6.4的应助被简历采纳,获得10
4秒前
4秒前
4秒前
4秒前
5秒前
lwh完成签到,获得积分20
6秒前
甘氨酸完成签到,获得积分20
6秒前
drccy完成签到,获得积分10
7秒前
8如有法规完成签到,获得积分10
7秒前
任性的如南完成签到,获得积分10
7秒前
niko发布了新的文献求助10
8秒前
爪子完成签到,获得积分10
8秒前
8秒前
念l完成签到,获得积分10
8秒前
8秒前
kke完成签到,获得积分10
8秒前
Winky发布了新的文献求助10
8秒前
9秒前
微眠完成签到,获得积分10
9秒前
隐形曼青的应助被梦梦梦采纳,获得10
9秒前
gentleripper发布了新的文献求助10
9秒前
littlejin完成签到 ,获得积分10
9秒前
巴拉巴拉巴拉拉完成签到,获得积分10
9秒前
LL发布了新的文献求助10
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8167280
求助须知:如何正确求助?哪些是违规求助? 9560076
关于积分的说明 21754886
捐赠科研通 7758257
什么是DOI,文献DOI怎么找? 3429309
关于科研通互助平台的介绍 2553653
邀请新用户注册赠送积分活动 2474136